首页> 外国专利> Combination of CpG and antibodies directed against CD19,CD20, CD22 or CD40 for the treatment or prevention of cancer.

Combination of CpG and antibodies directed against CD19,CD20, CD22 or CD40 for the treatment or prevention of cancer.

机译：CpG和针对CD19，CD20，CD22或CD40的抗体的组合，用于治疗或预防癌症。

页面导航

摘要
著录项
相似文献

摘要

The invention relates to methods and products for treating cancer. In particular the invention relates to combinations of nucleic acids and antibodies for the treatment and prevention of cancer. The invention also relates to diagnostic methods for screening cancer cells.

机译：本发明涉及用于治疗癌症的方法和产品。特别地，本发明涉及用于治疗和预防癌症的核酸和抗体的组合。本发明还涉及用于筛选癌细胞的诊断方法。

著录项

公开/公告号SI1296714T1

专利类型
公开/公告日2010-01-29

原文格式PDF
申请/专利权人 S FOR ENTERPRISE UNIVERSITY OF IOWA RESEARCH FOUNDATION IOWA CENTER;COLEY PHARMACEUTICAL GMBH;
展开▼

申请/专利号SI20010030937T
发明设计人 WEINER GEORGE;HARTMANN GUNTHER;
展开▼

申请日2001-06-22
分类号A61K39;G01N33/53;A61K39;A61K39/395;A61K45;A61K48;A61P35;A61P35/02;A61P35/04;A61P43;C07K16/28;C12Q1/02;
国家 SI
入库时间 2022-08-21 18:45:03

相似文献

专利
外文文献
中文文献